BOSTON, March 25, 2026 (GLOBE NEWSWIRE)-- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results